BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9971828)

  • 1. Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity.
    Bonzon C; Fan H
    J Virol; 1999 Mar; 73(3):2434-41. PubMed ID: 9971828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nonleukemogenic and wild-type Moloney murine leukemia virus on lymphoid cells in vivo: identification of a preleukemic shift in thymocyte subpopulations.
    Davis BR; Chandy KG; Brightman BK; Gupta S; Fan H
    J Virol; 1986 Nov; 60(2):423-30. PubMed ID: 3490580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis.
    Lander JK; Chesebro B; Fan H
    J Virol; 1999 Jul; 73(7):5671-80. PubMed ID: 10364317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
    Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
    Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
    Belli B; Patel A; Fan H
    J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
    Brightman BK; Farmer C; Fan H
    J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.
    Brightman BK; Rein A; Trepp DJ; Fan H
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2264-8. PubMed ID: 2006167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moloney murine leukemia virus-induced tumors show altered levels of proapoptotic and antiapoptotic proteins.
    Bonzon C; Fan H
    J Virol; 2000 Sep; 74(17):8151-8. PubMed ID: 10933726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation.
    Belli B; Fan H
    J Virol; 1994 Nov; 68(11):6883-9. PubMed ID: 7933068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow depletion by 89Sr complements a preleukemic defect in a long terminal repeat variant of Moloney murine leukemia virus.
    Li QX; Fan H
    J Virol; 1991 Aug; 65(8):4442-8. PubMed ID: 1649340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined infection by Moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic mice.
    Li QX; Fan H
    J Virol; 1990 Aug; 64(8):3701-11. PubMed ID: 2164592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preleukemic hematopoietic hyperplasia induced by Moloney murine leukemia virus is an indirect consequence of viral infection.
    Brightman BK; Davis BR; Fan H
    J Virol; 1990 Sep; 64(9):4582-4. PubMed ID: 2200891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
    Fan H; Mittal S; Chute H; Chao E; Pattengale PK
    J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference.
    Lavignon M; Evans L
    J Virol; 1996 Jun; 70(6):3852-62. PubMed ID: 8648721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
    Hanecak R; Pattengale PK; Fan H
    J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a preleukemic state induced by Moloney murine leukemia virus: evidence for two infection events during leukemogenesis.
    Davis BR; Brightman BK; Chandy KG; Fan H
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4875-9. PubMed ID: 3474632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice.
    Evans LH; Morrey JD
    J Virol; 1987 May; 61(5):1350-7. PubMed ID: 3033265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mink cell focus-forming murine leukemia virus infection induces apoptosis of thymic lymphocytes.
    Yoshimura FK; Wang T; Yu F; Kim HR; Turner JR
    J Virol; 2000 Sep; 74(17):8119-26. PubMed ID: 10933722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early (preleukemic) events in Moloney murine leukemia virus leukemogenesis.
    Fan H; Brightman BK; Belli B; Okimoto M; Tao M
    Leukemia; 1997 Apr; 11 Suppl 3():149-51. PubMed ID: 9209326
    [No Abstract]   [Full Text] [Related]  

  • 20. Moloney murine leukemia virus infects cells of the developing hair follicle after neonatal subcutaneous inoculation in mice.
    Okimoto MA; Fan H
    J Virol; 1999 Mar; 73(3):2509-16. PubMed ID: 9971836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.